2026 data FDA MAUDE openFDA FDA Class III

Agent, Absorbable Hemostatic, Collagen Based

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA Class III (highest risk, premarket approval required), regulated under 21 CFR §878.4490 (General, Plastic Surgery panel).

FDA MAUDE casebook

openFDA event book Agent, Absorbable Hemostatic, Collagen Based LIGHT-BOOK · MAUDE

#488 of 1000 · 2,108 reports · 1996–2026

  • BOOK 2,108 reports
  • RANK #488 of 1000
  • DEATH 92 death-typed
  • INJ 1,676 injury-typed
  • MALF 310 malfunction
  • SPAN 1996–2026
  • PEAK 2023: 271
  • PHOTO Bur

Nearest event-volume peer: Bur, Surgical, General & Plastic Surgery (2 report gap)

Agent, Absorbable Hemostatic, Collagen Based sits #488 of 1000 among tracked device types with 2,108 MAUDE reports spanning 1996–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Malfunction reports sit below the device-type norm

Agent, Absorbable Hemostatic, Collagen Based carries 14.7% MALFUNCTION-coded reports, 50.1pp below the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 4.4% corpus 1.5% · above corpus mean (+2.9 pp)
  • INJ 79.5% corpus 30.3% · above corpus mean (+49.2 pp)
  • MALF 14.7% corpus 64.8% · below corpus mean (-50.1 pp)

Lead product-problem code Adverse Event Without Identified Device or Use Problem is 27% of coded problems · Lead manufacturer ETHICON INC. accounts for 53% of manufacturer-tagged reports · Top event location is 57% of location-tagged rows .

Agent, Absorbable Hemostatic, Collagen Based in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Agent, Absorbable Hemostatic, Collagen Based carries 2,108 MAUDE reports, ranked #488 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Injury 1,676 (79.5%)
Malfunction 310 (14.7%)
Death 92 (4.4%)
16 (0.8%)
Other 14 (0.7%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 647 (22.4%)
Other 624 (21.6%)
R 472 (16.4%)
450 (15.6%)
Hospitalization 247 (8.6%)
O 197 (6.8%)
Death 78 (2.7%)
Life Threatening 44 (1.5%)
H 38 (1.3%)
L 33 (1.1%)
S 27 (0.9%)
D 15 (0.5%)
Disability 11 (0.4%)

Top Product Problems

Adverse Event Without Identified Device or Use Problem 598
Off-Label Use 282
Improper or Incorrect Procedure or Method 233
Insufficient Device Problem Information 209
Appropriate Device Problem Term/Code Not Available 153
Other (for use when an appropriate device code cannot be identified) 120
Unknown (for use when the device problem is not known) 99
Device Contamination with Chemical or Other Material 94
Patient-Device Incompatibility 68
Device Operates Differently Than Expected 65
Lack of Effect 46
Use of Device Problem 45
Reaction 38
Defective Device 29
Patient Device Interaction Problem 28
Migration or Expulsion of Device 17
Foreign material 16
Break 15
Explanted 15
Device Appears to Trigger Rejection 13

Yearly Trend

96
1996: 4
97
1997: 16
98
1998: 16
99
1999: 8
00
2000: 14
01
2001: 43
02
2002: 24
03
2003: 16
04
2004: 21
05
2005: 14
06
2006: 13
07
2007: 15
08
2008: 55
09
2009: 63
10
2010: 76
11
2011: 85
12
2012: 51
13
2013: 62
14
2014: 93
15
2015: 94
16
2016: 85
17
2017: 121
18
2018: 109
19
2019: 151
20
2020: 146
21
2021: 96
22
2022: 58
23
2023: 271
24
2024: 134
25
2025: 94
26
2026: 60

Reports fell to 94 in 2025, down from an average of 203 in the two years before.

Related Entities for Agent, Absorbable Hemostatic, Collagen Based

Event Locations

1,192 (56.5%)
I 719 (34.1%)
HOSPITAL 83 (3.9%)
OTHER 51 (2.4%)
NO INFORMATION 26 (1.2%)
UNKNOWN 14 (0.7%)
INVALID DATA 13 (0.6%)
AMBULATORY SURGICAL FACILITY 5 (0.2%)
HOME 3 (0.1%)
NOT APPLICABLE 1 (0.0%)
OUTPATIENT TREATMENT FACILITY 1 (0.0%)

Compare ETHICON INC. vs BAXTER HEALTHCARE CORPORATION →

Nationwide devices with a comparable volume-and-death footprint

Two openFDA-derived peer sets for Agent, Absorbable Hemostatic, Collagen Based: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (2,108 here).

Similar death-typed counts

Nearest other device types by death-typed report count (92 here), distinct from the volume row.

Disclaimer: MAUDE figures for Agent, Absorbable Hemostatic, Collagen Based are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Agent, Absorbable Hemostatic, Collagen Based; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.